Nasopharyngeal Carcinoma
A malignant tumor originating from the mucosal epithelium of the nasopharynx, strongly associated with Epstein-Barr virus infection, whose diagnostic and treatment pathways exhibit typical stage dependence.
Timeline (last 90 days)
NPC-RubricBench is a stage-aware benchmark for evaluating multi-stage clinical reasoning across the full course of nasopharyngeal carcinoma, based on longitudinal records of 405 patients from two cancer centers, covering 941 patient-stage units across six consecutive care stages and 17,688 patient-specific atomic criteria spanning five evaluation dimensions.
Nasopharyngeal carcinoma is a malignant tumor originating from the mucosal epithelium of the nasopharynx, with a markedly elevated incidence in southern China and Southeast Asia, and is highly associated with Epstein-Barr virus infection.
Early-stage nasopharyngeal carcinoma patients are treated mainly with radiotherapy, locally advanced disease often requires concurrent chemoradiotherapy, and the recurrent or metastatic stage involves chemotherapy, targeted therapy, and immunotherapy.
All Facts (3)
NPC-RubricBench is a stage-aware benchmark for evaluating multi-stage clinical reasoning across the full course of nasopharyngeal carcinoma, based on longitudinal records of 405 patients from two cancer centers, covering 941 patient-stage units across six consecutive care stages and 17,688 patient-specific atomic criteria spanning five evaluation dimensions.
50%UnverifiedNasopharyngeal carcinoma is a malignant tumor originating from the mucosal epithelium of the nasopharynx, with a markedly elevated incidence in southern China and Southeast Asia, and is highly associated with Epstein-Barr virus infection.
50%UnverifiedEarly-stage nasopharyngeal carcinoma patients are treated mainly with radiotherapy, locally advanced disease often requires concurrent chemoradiotherapy, and the recurrent or metastatic stage involves chemotherapy, targeted therapy, and immunotherapy.
50%